Oxygenta Pharmaceutical Board of Directors
Get the latest insights into the leadership at Oxygenta Pharmaceutical. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Sai Sudhakar Vankineni | Chairperson & Managing Director |
| Mr. Raghavender Rao Kanuganti | Executive Director |
| Mr. Sunil Vishram Chawda | Executive Director |
| Mrs. Sravani Reddy Gantla | Executive Director |
| Mr. Bharath Reddy Guntuku | Ind. Non-Executive Director |
| Mr. Vidya Sagar Devabhaktuni | Ind. Non-Executive Director |
| Mr. Sanagari Kondal Reddy | Ind. Non-Executive Director |
| Mrs. Padmaja Surapureddy | Ind. Non-Executive Director |
| Mrs. Aakanksha Sachin Dubey | Addnl.Independent Director |
Oxygenta Pharmaceutical Share price
OXYGENTAPH
74
2.30 (3.21%)Last updated on 4 Sep, 2025 | 15:40 IST
BUYSELL
Today's High
74.39
Today's Low
70.50
52 Week Low
37.50
52 Week High
133.50
The current prices are delayed, login to your account for live prices
LoginOxygenta Pharmaceutical FAQs
The board at Oxygenta Pharmaceutical consists of experienced professionals, including Dr. Sai Sudhakar Vankineni , Mr. Raghavender Rao Kanuganti , and others, overseeing the company’s strategic and corporate governance.
Directors at Oxygenta Pharmaceutical are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Sai Sudhakar Vankineni is the current chairman at Oxygenta Pharmaceutical.
Executive directors at Oxygenta Pharmaceutical are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Oxygenta Pharmaceutical adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Oxygenta Pharmaceutical, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.